---
category: news
title: "Pluristem joins CRISPR-IL to develop next-gen genome editing products"
excerpt: "We see cell therapy and gene editing as highly synergistic methods to treat and cure diseases using advanced technologies,‚Äù said Pluristem CEO Yaky Yanay."
publishedDateTime: 2020-06-04T15:00:00Z
webUrl: "https://www.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337"
ampWebUrl: "https://m.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337/amp"
cdnAmpWebUrl: "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337/amp"
type: article
quality: 44
heat: 44
published: false

provider:
  name: The Jerusalem Post Blogs
  domain: jpost.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/445027"
    width: 640
    height: 428
    title: "Pluristem joins CRISPR-IL to develop next-gen genome editing products"

secured: "66rdlymKHsZFrnJbuoMyzEPdtE1rIJpWNiDPcG4yuKhA0DOdb25euxDrjhw7Qpvy0/gzJkC9tw/qo2r6GOZ/MHw1qeBo1SbmRHFBKAVxITrawISL4z82nsRpvBdG/yvs1/EAVHphOYCH8Amo1RqvPYM6Wo1O7yqKv0+1VZVd2dGrUJ6SvJapb1kpeY5PYVPeOUzNedAOSWIfxijCgXynEKlG5YpwqPRwoAItPgdaaBmsGIeiU1wUflCH5NW/iqE4H/M6Tl6486hZHd90u8qUIquFHvYdG1dvaMa7Vvbosd5k7ZsMmhm58Q9A/n0re5P2;WNy3KtNtjRc//u8TWXQ/vw=="
---

